Reuters
• Akash Sriram, Mariam E Sunny
Pharmaceutical companies are preparing to move drug research and manufacturing into commercial low Earth orbit platforms as the International Space Station approaches the end of its operational life. The industry is also working with regulators to establish rules for producing medicines in space.
Commercial Space
Latest source-backed stories
As SpaceX winds down the Falcon 9 launch program, rival launch providers say the market is approaching a reset. Their view challenges the launch industry’s prevailing price-per-kilogram model and signals a potential shift in how providers compete and structure commercial launch offerings.
Intuitive Machines is evaluating how satellite capabilities obtained through an acquisition could support its entry into the emerging orbital data center market. The effort would extend the company’s commercial space portfolio beyond its existing activities and position it around a nascent space-infrastructure opportunity.
Pharmaceutical companies are preparing to move drug research and manufacturing into commercial low Earth orbit platforms as the International Space Station approaches the end of its operational life. The industry is also working with regulators to establish rules for producing medicines in space.
Europe has demonstrated that it can fund ambitious space initiatives, but globally competitive companies require more than project financing. Standards, public procurement and sustained strategic continuity are needed to turn fragmented programs into a durable commercial market capable of supporting international-scale businesses.
High activity
EnduroSat’s $205 million funding round helped push European NewSpace investment above €1 billion in September, while Vantor selected the Bulgarian company and CACI International to build a 24-satellite Earth-imaging constellation designed for revisits as frequent as every 15 minutes.
The SpaceX team responsible for landing Falcon 9 boosters received the inaugural Neil Armstrong Space Prize at a ceremony in Washington, D.C., on Sept. 15. The award recognizes the team’s achievement in developing and executing reusable rocket-landing operations.
Bulgarian satellite manufacturer EnduroSat has raised $205 million to accelerate production in Europe and the United States, citing growing demand for its “constellation-as-a-service” model. The financing underscores continued investment in scalable satellite manufacturing and commercially delivered constellation capabilities.
In-space mobility company Impulse Space has raised an additional $308 million, expanding a funding round it announced at $500 million in June. The latest financing underscores continued investor support for commercial services designed to move payloads in orbit.
Create a free account to see more recent Commercial Space stories and keep bookmarks in one place.
